Summary of Benefit-risk Assessment Reports
The reports contain a summary of the quality, safety and efficacy of approved new chemicals and biologics, and HSA's benefit-risk assessment for the approvals.
4 articles
30 April 2026
Nemluvio Powder and Solvent for solution for injection in Pre-filled Pen/Syringe 30mg
The summary report for this therapeutic product is available for download
New drug application
9 April 2026
Veoza Film coated Tablet
The summary report for this therapeutic product is available for download
New drug application
9 April 2026
Ebglyss Solution for Injection in Pre-filled Pen 250mg/2ml
The summary report for this therapeutic product is available for download
New drug application
1 January 2025
Archive
View summary reports of therapeutic products approved from 2020-2025
Archive
